These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 88383)

  • 1. The effect of O-betahydroxyethyl-rutosides (HR) on the number of platelet-leukocyte aggregates in patients with occlusive arterial disease.
    Bielawiec M; Kiersnowska-Rogowska B; Dabrowski S; Lukjan H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(1):103-8. PubMed ID: 88383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effect of high doses of o-betahydroxyethyl-rutosides in patients with occlusive arterial disease.
    Bielawiec M; Lukjan H; Kiersnowska-Rogowska B; Dabrowski S
    Bibl Anat; 1979; (18):378-81. PubMed ID: 496871
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical effect of O-betahydroxyethyl-rutosides (HR) in patients with occlusive arterial disease.
    Bielawiec M; Lukjan H; Grabowski R; Myśliwiec M; Korfel B
    Bibl Anat; 1977; (16 Pt 2):152-4. PubMed ID: 603503
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of hydroxyethylrutoside and its combination with acetylsalicylic acid in patients with obliterative atherosclerosis.
    Roztocil K; Oliva I; Prerovský I; Linhart J
    Cor Vasa; 1989; 31(2):128-33. PubMed ID: 2663343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of HR (O-Beta-Hydroxyethylo-Rutoside, Venoruton) on the deformability of erythrocytes in patients with arteriosclerosis obliterans of lower limbs.
    Lukjan H; Rość D; Chyzy R; Bodzenta A; Szpak A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):191-6. PubMed ID: 2581865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of O-(beta-hydroxyethyl)-rutosides at high dosage in counteracting the unwanted activity of oral contraceptives on venous function.
    Cappelli R; Pecchi S; Oberhauser V; Forconi S; Di Perri T
    Int J Clin Pharmacol Res; 1987; 7(4):291-9. PubMed ID: 3596872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some haemorheological factors and transcutaneous PO2 in patients with a peripheral arterial occlusive disease after treatment with naftidrofuryl.
    Krupiński K; Bielawiec M; Szpak A; Płonowski A
    Mater Med Pol; 1994; 26(1):17-20. PubMed ID: 7857406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.
    Klinkhardt U; Bauersachs R; Adams J; Graff J; Lindhoff-Last E; Harder S
    Clin Pharmacol Ther; 2003 Mar; 73(3):232-41. PubMed ID: 12621388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of large doses of a flavonoid O-(betahydroxyethyl)-rutoside on some aspects of venous circulation].
    Forconi S; Guerrini M
    Clin Ter; 1977 Feb; 80(3):229-55. PubMed ID: 852233
    [No Abstract]   [Full Text] [Related]  

  • 10. 5-Year control and treatment of edema and increased capillary filtration in venous hypertension and diabetic microangiopathy using O-(beta-hydroxyethyl)-rutosides: a prospective comparative clinical registry.
    Belcaro G; Cesarone MR; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG
    Angiology; 2008; 59 Suppl 1():14S-20S. PubMed ID: 18287163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of acute symptoms of hemorrhoid disease with high-dose oral O-(beta-hydroxyethyl)-rutosides].
    Annoni F; Boccasanta P; Chiurazzi D; Mozzi E; Oberhauser V
    Minerva Med; 1986 Sep; 77(37):1663-8. PubMed ID: 3531924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of hydroxyethylrutosides (HR): metabolism of [14C]-HR in man.
    Hackett AM; Griffiths LA; Luyckx AS; van Cauwenberge H
    Arzneimittelforschung; 1976; 26(5):925-8. PubMed ID: 989368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of ciclonicate in the treatment of obliterative arteriopathies of the lower limbs].
    Licata G; Pinto A; Parrinello G; Salli L; Indovina I
    Clin Ter; 1985 Mar; 112(6):503-13. PubMed ID: 4017475
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of troxerutin on platelet aggregation in patients with arteriosclerosis].
    Myśliwiec M; Bodzenta A
    Pol Tyg Lek; 1983 Oct; 38(44):1367-8. PubMed ID: 6674961
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of O-(beta-hydroxyethyl)-rutosides (HR) on the skin capillary resistance of rats.
    Gábor M
    Arzneimittelforschung; 1981; 31(3):442-5. PubMed ID: 7194669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of the acetylosalicyd acid (ASA) and ticlopidine therapy on clinical condition and parameters of blood platelets in patients with peripheral arterial occlusive disease (PAOD)].
    Leo W; Westrych R; Bissinger A; Okraszewski J; Baj Z
    Pol Merkur Lekarski; 2007 Nov; 23(137):335-9. PubMed ID: 18361314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled nitric oxide inhibits platelet-leukocyte interactions in patients with acute respiratory distress syndrome.
    Gries A; Herr A; Kirsch S; Günther C; Weber S; Szabo G; Holzmann A; Böttiger BW; Martin E
    Crit Care Med; 2003 Jun; 31(6):1697-704. PubMed ID: 12794407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O-(beta-hydroxyethyl)-rutosides systemic and local treatment in chronic venous disease and microangiopathy: an independent prospective comparative study.
    Belcaro G; Rosaria Cesarone M; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG
    Angiology; 2008; 59 Suppl 1():7S-13S. PubMed ID: 18287162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double blind trial of oral O. B-hydroxyethyl rutosides for stasis leg ulcers.
    Mann RJ
    Br J Clin Pract; 1981 Feb; 35(2):79-81. PubMed ID: 7020736
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic investigations with venosan in veinous disease in the legs (author's transl)].
    Juon M; Messelhäuser I
    Schweiz Rundsch Med Prax; 1976 Jun; 65(24):755-8. PubMed ID: 981190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.